NOTCH1 and head and neck cancer: NOTCH1 and Notch pathway are generally regarded as having a tumor suppressor function in head and neck cancer (67) which hampers the possibility to use γ-secretase inhibitors that are in development for cancers with Notch pathway activation (68).